IndiaMart
FIEO
PT-141 (Bremelanotide) 10mg is a synthetic peptide derived from Melanotan II, developed for its role in sexual wellness and neuroendocrine research. Unlike traditional hormone-based agents, PT-141 acts directly through the melanocortin receptors in the central nervous system, influencing sexual arousal pathways without altering hormonal levels.
This peptide is widely studied for its potential to enhance libido, improve sexual function, and support vascular performance in both male and female subjects. It also shows promise in research related to neurological signaling, mood regulation, and vascular health.
BLUEPILL EXPRESS, a globally recognized merchant exporter, supplies PT-141 10mg manufactured under GMP-certified facilities in India and China, ensuring high purity, stability, and reproducibility for research and pharmaceutical formulation development. Each batch undergoes HPLC and Mass Spectrometry (MS) testing to confirm identity, potency, and purity.
Key Features of PT-141 (Bremelanotide) 10mg:
- Synthetic melanocortin receptor agonist for sexual and neurological research
- Promotes sexual function and vascular response in preclinical studies
- Acts via CNS pathways without altering hormonal balance
- High-purity peptide tested using HPLC and MS
- GMP-certified manufacturing available in India and China
- Exported globally by BLUEPILL EXPRESS – Merchant Exporter of Peptides and APIs
- Supplied with COA, MSDS, and export compliance documents
- Offered in bulk, OEM, and private-label packaging options
- Suitable for biomedical, neuroendocrine, and vascular research
- Supports sexual wellness, CNS modulation, and hormone-free studies
BLUEPILL EXPRESS is a leading merchant exporter of research-grade peptides and APIs, offering products manufactured in India and China to meet diverse international research requirements. The company specializes in pharmaceutical export logistics, regulatory documentation, and global compliance, providing reliable sourcing for academic, biotech, and pharmaceutical clients.
The export portfolio includes advanced peptides such as Melanotan II (MT-2), CJC-1295, Ipamorelin, GHRP-6, and Thymosin Alpha-1, ensuring complete coverage of endocrine, metabolic, and regenerative peptide research needs.
